STOCK TITAN

[144] Lincoln National Corp. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 filing for Lincoln National Corp. (LNC) reports a proposed sale of 6,362 common shares held at UBS Financial Services with an aggregate market value of $260,020.34, and an approximate sale date of 08/15/2025 on the NYSE. The shares were acquired the same day, 08/15/2025, through an ESOP exercise from Lincoln National Corp., and payment was wired. The filing also discloses a prior sale by Brian Kroll of 10,075 common shares on 05/29/2025 generating gross proceeds of $333,483. The filer certifies no undisclosed material adverse information and includes standard Rule 144 representations.

Segnalazione Form 144 per Lincoln National Corp. (LNC) indica la proposta di vendita di 6.362 azioni ordinarie detenute presso UBS Financial Services per un valore complessivo di mercato di $260.020,34, con data di vendita prevista il 15/08/2025 sulla NYSE. Le azioni sono state acquisite lo stesso giorno, il 15/08/2025, tramite esercizio ESOP da Lincoln National Corp., con pagamento effettuato tramite bonifico. La comunicazione riporta inoltre una vendita precedente da parte di Brian Kroll di 10.075 azioni ordinarie il 29/05/2025, che ha generato proventi lordi di $333.483. Il dichiarante certifica l'assenza di informazioni materiali non divulgate e include le dichiarazioni standard previste dalla Regola 144.

Presentación del Formulario 144 para Lincoln National Corp. (LNC) informa una propuesta de venta de 6.362 acciones ordinarias depositadas en UBS Financial Services por un valor de mercado agregado de $260.020,34, con fecha aproximada de venta el 15/08/2025 en la NYSE. Las acciones fueron adquiridas ese mismo día, el 15/08/2025, mediante el ejercicio de un ESOP de Lincoln National Corp., con el pago transferido por cable. La presentación también revela una venta previa realizada por Brian Kroll de 10.075 acciones ordinarias el 29/05/2025, que generó ingresos brutos de $333.483. El declarante certifica que no existe información material no divulgada e incluye las representaciones estándar de la Regla 144.

Lincoln National Corp.(LNC)에 대한 Form 144 제출은 UBS Financial Services에 보관된 6,362 보통주를 총 시가 $260,020.34에 매각할 예정임을 보고하며, NYSE에서의 예정 매각일은 2025-08-15로 기재되어 있습니다. 해당 주식은 같은 날인 2025-08-15에 Lincoln National Corp.의 ESOP 행사로 취득되었고, 대금은 전신 송금으로 지급되었습니다. 제출서류는 또한 Brian Kroll이 2025-05-2910,075 보통주를 매각하여 총수익 $333,483를 얻은 사실을 공개합니다. 제출인은 미공개 중대한 정보가 없음을 인증하고 규칙 144의 표준 진술을 포함합니다.

Dépôt du Formulaire 144 pour Lincoln National Corp. (LNC) signale une vente proposée de 6 362 actions ordinaires détenues chez UBS Financial Services pour une valeur marchande totale de $260 020,34, avec une date de vente approximative au 15/08/2025 sur la NYSE. Les actions ont été acquises le même jour, le 15/08/2025, via l'exercice d'un ESOP de Lincoln National Corp., et le paiement a été effectué par virement. Le dépôt dévoile également une vente antérieure par Brian Kroll de 10 075 actions ordinaires le 29/05/2025, générant un produit brut de $333 483. Le déclarant certifie qu'il n'existe pas d'informations matérielles non divulguées et inclut les déclarations standard prévues par la Règle 144.

Form-144-Meldung für Lincoln National Corp. (LNC) meldet einen geplanten Verkauf von 6.362 Stammaktien, verwahrt bei UBS Financial Services, mit einem Gesamtmarktwert von $260.020,34 und einem ungefähren Verkaufstermin am 15.08.2025 an der NYSE. Die Aktien wurden am selben Tag, dem 15.08.2025, durch Ausübung eines ESOP von Lincoln National Corp. erworben; die Zahlung wurde per Überweisung geleistet. Die Meldung nennt außerdem einen früheren Verkauf durch Brian Kroll von 10.075 Stammaktien am 29.05.2025, der Bruttoerlöse von $333.483 einbrachte. Der Einreichende bestätigt, dass keine nicht offengelegten wesentlichen Informationen vorliegen, und enthält die üblichen Zusicherungen gemäß Regel 144.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine Rule 144 sale by an insider; amounts are modest relative to large-cap market caps and likely non-material.

The filing shows a proposed sale of 6,362 shares valued at $260k and a prior sale of 10,075 shares for $333k. The acquisition via ESOP exercise on the same date and sale through UBS indicates internal compensation shares being monetized under Rule 144. There is no disclosure of material non-public information and no unusual restrictions noted. For most investors, these transactions represent standard insider liquidity rather than a change in corporate operations or financial condition.

TL;DR: Disclosure complies with Rule 144 formalities; representation about lack of undisclosed material information is included.

The form properly identifies the broker, class, share counts, and sale timing. The statement asserting the signer is unaware of undisclosed material adverse information aligns with required certifications. The filing notes an ESOP exercise as the acquisition source and a wire payment, which clarifies the economic provenance of the shares. No governance irregularities or compliance issues are evident from the provided text.

Segnalazione Form 144 per Lincoln National Corp. (LNC) indica la proposta di vendita di 6.362 azioni ordinarie detenute presso UBS Financial Services per un valore complessivo di mercato di $260.020,34, con data di vendita prevista il 15/08/2025 sulla NYSE. Le azioni sono state acquisite lo stesso giorno, il 15/08/2025, tramite esercizio ESOP da Lincoln National Corp., con pagamento effettuato tramite bonifico. La comunicazione riporta inoltre una vendita precedente da parte di Brian Kroll di 10.075 azioni ordinarie il 29/05/2025, che ha generato proventi lordi di $333.483. Il dichiarante certifica l'assenza di informazioni materiali non divulgate e include le dichiarazioni standard previste dalla Regola 144.

Presentación del Formulario 144 para Lincoln National Corp. (LNC) informa una propuesta de venta de 6.362 acciones ordinarias depositadas en UBS Financial Services por un valor de mercado agregado de $260.020,34, con fecha aproximada de venta el 15/08/2025 en la NYSE. Las acciones fueron adquiridas ese mismo día, el 15/08/2025, mediante el ejercicio de un ESOP de Lincoln National Corp., con el pago transferido por cable. La presentación también revela una venta previa realizada por Brian Kroll de 10.075 acciones ordinarias el 29/05/2025, que generó ingresos brutos de $333.483. El declarante certifica que no existe información material no divulgada e incluye las representaciones estándar de la Regla 144.

Lincoln National Corp.(LNC)에 대한 Form 144 제출은 UBS Financial Services에 보관된 6,362 보통주를 총 시가 $260,020.34에 매각할 예정임을 보고하며, NYSE에서의 예정 매각일은 2025-08-15로 기재되어 있습니다. 해당 주식은 같은 날인 2025-08-15에 Lincoln National Corp.의 ESOP 행사로 취득되었고, 대금은 전신 송금으로 지급되었습니다. 제출서류는 또한 Brian Kroll이 2025-05-2910,075 보통주를 매각하여 총수익 $333,483를 얻은 사실을 공개합니다. 제출인은 미공개 중대한 정보가 없음을 인증하고 규칙 144의 표준 진술을 포함합니다.

Dépôt du Formulaire 144 pour Lincoln National Corp. (LNC) signale une vente proposée de 6 362 actions ordinaires détenues chez UBS Financial Services pour une valeur marchande totale de $260 020,34, avec une date de vente approximative au 15/08/2025 sur la NYSE. Les actions ont été acquises le même jour, le 15/08/2025, via l'exercice d'un ESOP de Lincoln National Corp., et le paiement a été effectué par virement. Le dépôt dévoile également une vente antérieure par Brian Kroll de 10 075 actions ordinaires le 29/05/2025, générant un produit brut de $333 483. Le déclarant certifie qu'il n'existe pas d'informations matérielles non divulguées et inclut les déclarations standard prévues par la Règle 144.

Form-144-Meldung für Lincoln National Corp. (LNC) meldet einen geplanten Verkauf von 6.362 Stammaktien, verwahrt bei UBS Financial Services, mit einem Gesamtmarktwert von $260.020,34 und einem ungefähren Verkaufstermin am 15.08.2025 an der NYSE. Die Aktien wurden am selben Tag, dem 15.08.2025, durch Ausübung eines ESOP von Lincoln National Corp. erworben; die Zahlung wurde per Überweisung geleistet. Die Meldung nennt außerdem einen früheren Verkauf durch Brian Kroll von 10.075 Stammaktien am 29.05.2025, der Bruttoerlöse von $333.483 einbrachte. Der Einreichende bestätigt, dass keine nicht offengelegten wesentlichen Informationen vorliegen, und enthält die üblichen Zusicherungen gemäß Regel 144.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for Lincoln National Corp. (LNC) disclose?

The form discloses a proposed sale of 6,362 common shares valued at $260,020.34 with an approximate sale date of 08/15/2025, sold via UBS on the NYSE.

How were the 6,362 LNC shares acquired according to the filing?

The shares were acquired on 08/15/2025 through an ESOP exercise from Lincoln National Corp., and payment was made by wire.

Did the filer report any recent sales of LNC shares in the past three months?

Yes. The filing discloses a sale by Brian Kroll of 10,075 common shares on 05/29/2025 for gross proceeds of $333,483.

Which broker and exchange are named for the proposed sale?

The broker is UBS Financial Services Inc in Weehawken, NJ, and the sale is listed as occurring on the NYSE.

Does the filer represent possession of any undisclosed material information?

The filer certifies by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.
Lincoln Natl Corp Ind

NYSE:LNC

LNC Rankings

LNC Latest News

LNC Latest SEC Filings

LNC Stock Data

7.75B
170.04M
10.16%
70.4%
3.55%
Insurance - Life
Life Insurance
Link
United States
RADNOR